APLS · Apellis Pharmaceuticals, Inc.
SELL 91%
193
Total trades
22
Insiders on record
91%
Avg confidence
SELL
Signal direction
Recent insider trades
| Date | Insider | Action | Type | Value | Confidence |
|---|---|---|---|---|---|
| Feb 11, 2026 | Mark Jeffrey Delong | SELL | Open-market sale | 8.2K | 0.88 |
| Jan 22, 2026 | David Watson | SELL | Open-market sale | 170.5K | 0.95 |
| Jan 22, 2026 | James George Chopas | SELL | Open-market sale | 44.9K | 0.91 |
| Jan 22, 2026 | Pascal Deschatelets | SELL | Open-market sale | 129K | 0.94 |
| Jan 22, 2026 | Timothy Eugene Sullivan | SELL | Open-market sale | 223.9K | 0.99 |
| Jan 22, 2026 | Mark Jeffrey Delong | SELL | Open-market sale | 73.4K | 0.91 |
| Jan 22, 2026 | Cedric Francois | SELL | Open-market sale | 591.8K | 1.00 |
| Jan 22, 2026 | Caroline Baumal | SELL | Open-market sale | 60.9K | 0.91 |
| Jan 22, 2026 | Nur Nicholson | SELL | Open-market sale | 168.1K | 0.95 |
| Jan 20, 2026 | Pascal Deschatelets | SELL | Open-market sale | 18K | 0.89 |
Apellis Pharmaceuticals, Inc. has 193 total insider trades on record. Sign up to see the full history, track records, and evidence trails.
Want alerts when insiders trade APLS?
Sign up free to get notified, see the full trade history, and track insider conviction over time.
Sign up freeInsiderTrack aggregates publicly available SEC Form 4 filings. Data is provided for informational purposes only and should not be construed as investment advice. Always do your own research before making investment decisions.